Back to search

Article

Oncological Outcomes of Patients with Peritoneal Metastasis–only Colorectal Cancer Treated with First-line Bevacizumab and FOLFIRI through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis–only, and Lung Metastasis–only

2021-07-14

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold>The prognosis of metastatic colorectal cancer (mCRC) depends on the metastatic site and systemic therapy regimen. Peritoneal metastases are associated with a relatively unfavorable prognosis among patients with mCRC. In this article, we present the treatment outcomes of patients with peritoneal carcinomatosis (PC)–only, liver metastasis (LiM)–only, and lung metas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
571e97b7-e3e2-5002-8bc7-dd0436416498
DOI
10.21203/rs.3.rs-708537/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oncological Outcomes of Patients with Peritoneal Metastasis–only Colorectal Cancer Treated with First-line Bevacizumab and FOLFIRI through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis–only, and Lung Metastasis–onlyDOI 10.21203/rs.3.rs-708537/v1
Defining patient populations that may derive survival benefit from local radiotherapy in Colon cancer with liver metastases: a real-world study using SEER and an independent cohortSemantic proximity
Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China.Semantic proximity
Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countries.Semantic proximity
BRAF V600E-Mutant Colorectal Cancers with Liver-Only Metastases: A Retrospective Study.Semantic proximity
[Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer].Semantic proximity
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.Semantic proximity
Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study: The EMOGI-CRC01 StudySemantic proximity
Real-World Outcomes of First-line and Second-line Chemotherapy with Dabrafeniband Cetuximab in BRAF V600E-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single CenterSemantic proximity
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistanceSemantic proximity
Clinicopathological characteristics and prognosis of patients with mucious adenocarcinoma originating from the left colon, right colon, or rectum: A nationwide retrospective study in ChinaSemantic proximity
Association of RAS mutations with early progression after first-line systemic therapy in patients with initially unresectable colorectal cancer liver metastasisSemantic proximity
A multiple metastatic colon cancer patient with extra-long survival and acquired BRAF mutation: case report and literature reviewSemantic proximity
Select a neighboring publication to make it the new centre.